TriSalus Life Sciences (TLSI) Cost of Revenue (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Cost of Revenue of $1.2 million for Q1 2026, down 17.73% year-over-year from $1.5 million in Q1 2025, and down 30.19% quarter-over-quarter from $1.8 million in Q4 2025.
TriSalus Life Sciences (TLSI) Cost of Revenue (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Cost of Revenue history runs 5 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Cost of Revenue fell 17.73% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $6.7 million (up 44.8% YoY), while the FY2025 annual figure was $7.0 million, up 69.75% from the prior year.
- Cost of Revenue for Q1 2026 stood at $1.2 million, down from $1.8 million in the prior quarter.
- The five-year high for Cost of Revenue was $1.9 million in Q3 2025, with the low at $582000.0 in Q4 2023.
- The 5-year median for Cost of Revenue is $971000.0 (2024), against an average of $1.1 million.
- The sharpest annual moves came in 2023 and 2024: Cost of Revenue retreated 28.68% in 2023, then surged 108.93% in 2024.
- TriSalus Life Sciences' Cost of Revenue stood at $816000.0 in 2022, then declined by 28.68% to $582000.0 in 2023, then surged by 108.93% to $1.2 million in 2024, then surged by 44.9% to $1.8 million in 2025, then plunged by 30.19% to $1.2 million in 2026.
- Business Quant data shows TLSI's Cost of Revenue at $1.2 million in Q1 2026, $1.8 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 808.60 Mn |
| 10 | TriSalus Life Sciences | 307.64 Mn | 261.36 Mn | 9.90 Mn | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.51 Mn |
| Jun 30, 2026 | 1.51 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.76 Mn |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 912,000.00 |
| Jun 30, 2024 | 912,000.00 |
| Mar 31, 2024 | 971,000.00 |
| Mar 31, 2024 | 971,000.00 |